Table 2.

Summary of end of treatment Deauville scores and subsequent therapies for subjects modified PFS events per IRF

A+AVDABVD
n = 250n = 247
Number with events per IRF, n (%)38 (15)57 (23)
Reason leading to modified PFS event, n (%)
Progressive disease28 (11)39 (16)
Death due to any cause6 (2)10 (4)
Receipt of additional therapy after non-CRa, n (%)4 (2)8 (3)
 Salvage chemotherapy3/4 (75)7/8 (88)
  Deauville score at end of treatmentb
   300
   42/3 (67)2/7 (29)
   51/3 (33)5/7 (71)
 Radiation1/4 (25)1/8 (13)
  Deauville score at end of treatmentb
   31/1 (100)0
   401/1 (100)
   500
  • aConfirmed noncomplete responders (Deauville 3, 4, or 5) with receipt of additional anticancer treatment after completion of first-line therapy.

  • bEvidence of a non-CR required an EOT Deauville score ≥3.